Abnormal uterine bleeding associated with hormonal contraception

American Family Physician

Volumn 65, Issue 10, 2002, Pages

  Schrager, Sarina ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; DESOGESTREL; ESTRADIOL; ESTRASE; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; HORMONE; IBUPROFEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NONSTEROID ANTIINFLAMMATORY AGENT; NORETHISTERONE; NORGESTREL; ORAL CONTRACEPTIVE AGENT;

DRUG IMPLANT; HORMONAL CONTRACEPTION; HUMAN; ORAL CONTRACEPTION; PATIENT COUNSELING; PILL; PREGNANCY; REVIEW; UTERUS BLEEDING;

CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HUMANS; LEVONORGESTREL; PROGESTINS; UTERINE HEMORRHAGE;

EID: 0037093417     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Experiences of injectable contraceptive users in an urban setting
2. Depot medroxyprogesterone acetate. Patterns of use and reasons for discontinuation
3. Bleeding complaints during the first year of Norplant implants use and their impact on removal rate
4. Oral contraceptive discontinuation: A prospective evaluation of frequency and reasons
5. Unintended pregnancies and use, misuse and discontinuation of oral contraceptives
6. Contraceptive efficacy
7. Progestin-only oral contraceptives
8. Depo-Provera, Norplant, and progestin-only pills
9. Management of bleeding in women using subdermal implants
10. Cycle control with oral contraceptives: A review of the literature
11. Oral contraceptive estrogen dose considerations
12. Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20micrograms ethinyl estradiol
13. Cycle control with oral contraceptives containing 20 micrograms of ethinyl estradiol. A multicenter, randomized comparison of levonorgestrel/ethinyl estradiol (100 micrograms/20 micrograms) and northethindrone/ethinyl estradiol (1000 micrograms/20 micrograms)
14. Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: A randomized trial of 20 micrograms and 35 micrograms estrogen preparations
15. A comparison of cycle control with monophasic levonorgestrel/ethinylestradiol 100 micrograms/20 micrograms versus triphasic northethindrone/ethinylestradiol 500-750-1000 micrograms/35 micrograms: A multicenter, randomized, open-label study
16. A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic northethindrone with ethinyl estradiol
17. Menstrual impact of contraception
18. Approach to common side effects
19. Smoking and cycle control among oral contraceptive users
20. Chlamydia trachomatis in patients who used oral contraceptives and had intermenstrual spotting
21. The pill: Combined oral contraceptives
22. Update on oral contraceptive pills
23. Clinical assessment of treatments for prolonged bleeding in users of Norplant implants
24. Hormonal treatment for bleeding irregularities in Norplant implant users
25. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception
26. Treatment of bleeding problems associated with progestin-only contraceptives: Survey results
27. Depo-Provera in adolescents: Effects of early second injection or prior oral contraception
28. The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use
29. Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception